Point of Care Tests in the Management of Very Early Medical Abortion
ConditionAbortion Early
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age16-55
SponsorUniversity of Edinburgh
About this trial
This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \<6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.
Eligibility criteria
Qualifiers
Positive pregnancy test
Less than six weeks gestation based upon Last Menstrual Period (LMP)
No evidence of definite intrauterine pregnancy on ultrasound
No signs or symptoms or significant risk factors for ectopic
Disqualifiers
Pain and/or bleeding
Significant risk factors for ectopic (previous ectopic, sterilisation, tubal disease, intrauterine device in situ)
Suspicious features for ectopic on ultrasound (adnexal mass, moderate free fluid)
Unable to provide blood sample
Trial design
Treatments tested in this trial
- Blood test
- Participant Questionnaire
Treatment groups
130 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Edinburgh
Lead sponsor
NORDIC pharma (funding)
Collaborator
NHS Lothian
Collaborator
Karolinska Institutet
Collaborator
Karolinska University Hospital
Collaborator
Göteborg University
Collaborator
Sahlgrenska University Hospital
Collaborator
Source ClinicalTrials.gov